Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Valsartan Cancer Risk


The drug Valsartan (a generic version of Diovan), which is prescribed to treat high blood pressure and prevent heart failure, has been recalled worldwide after it was found to contain N-nitrosodimethylamine (NDMA), a known carcinogen. Valsartan contamination from a Chinese manufacturing plant may date back to 2012, potentially exposing many patients to Valsartan cancer risk, liver damage and tumors. It has been on the market for 15 years.

FREE VALSARTAN CANCER LAWSUIT EVALUATION

Send your Valsartan Cancer claim to a lawyer who will review your claim at NO COST or obligation.
GET LEGAL HELP NOW

Valsartan Carcinogen

NDMA, or N-nitrosodimethylamine, is a chemical used in rocket fuel and it is classified as a carcinogen. Short-term exposure to toxic NDMA can cause liver damage while long-term exposure can increase the risk of liver, kidney, and lung tumors. Investigators found that NDMA had contaminated Valsartan’s production at Zhejiang Huahai Pharmaceuticals in Linhai, China, possibly since 2012 when the company changed its manufacturing process and produced NDMA as a by-product.

Valsartan Recall

The FDA recall on July 17 involves medicines from: Solco Healthcare, Major Pharmaceuticals, and Teva. Valsartan-containing products made by Teva Pharmaceuticals and Prinston Pharmaceuticals Inc. are labeled as A-S Medication Solutions LLC, AvKARE and RemedyRepack, according to the FDA. Two of these companies, A-S Medication and RemedyRepack, may also distribute valsartan products not affected by the recall.

The following additional re-packagers are recalling or are expected to recall valsartan-containing products:
  • H. J. Harkins Company Inc. (this company was not originally included on either list)
  • Lake Erie Medical, doing business as Quality Care Products LLC
  • NuCare Pharmaceuticals Inc.
  • Northwind Pharmaceuticals
  • Proficient Rx
  • Bryant Ranch Prepack Inc.


Valsartan Medication

The FDA approved Valsartan as a treatment for high blood pressure, or hypertension, in adults and children age six and up. It’s also approved for use in adults to treat heart failure and to reduce the risk of death in patients who recently had a heart attack. Valsartan is in a class of hypertension medications known as angiotensin II receptor agonists that reduce the constriction of blood vessels so that blood flows more freely. Valsartan is a stand-alone medication or valsartan HCTZ, which combines valsartan with the diuretic hydrochlorothiazide.

Valsartan Lawsuits

Valsartan lawsuits allege the medication can be tainted with N-nitrosodimethylamine (NDMA), a known cancer-causing substance. Attorneys are investigating claims from clients who took valsartan and have been diagnosed with liver damage, tumors, or lung cancer.

A proposed national class action has begun in Canada on behalf of all Canadians who purchased or ingested one or more of the valsartan medications which have been recalled, according to the CBC. The plaintiff claims that five pharmaceutical companies who supplied contaminated valsartan nationwide were negligent in their manufacturing of the drugs and in their failure to implement appropriate quality control testing when they received raw material from their supplier in China. The five defendants in the proposed Valsartan class action lawsuit are Teva Canada Limited, Sandoz Canada Inc., Pro Doc Limitee, Sanis Health Inc., and Sivem Pharmaceuticals ULC.

According to Radio Canada International,(July 18, 2018) the five pharmaceutical companies involved have so far not released information on the levels of contaminant, nor the number of years the chemical was in their products, nor what the potential health implications are. One Canadian attorney said the requests for a class-action suit already have over a thousand applicants, and he expects tens of thousands more--the recall could impact 4.4 million Canadians who have been prescribed these drugs.

“The recall is huge, based on the volume and the large number of patients it could have impacted,” John Brito, of the market research firm Fore Pharma told the New York Times(July 16, 2018). If you developed cancer or liver damage after taking the medication, you may have a legal claim against Valsartan manufacturers.

Valsartan Cancer Risk Legal Help

If you or a loved one has suffered similar damages or injuries, please fill in our form and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Published on Jul-31-18

VALSARTAN CANCER LEGAL ARTICLES AND INTERVIEWS

Valsartan Recall Lawsuits Filed over Alleged Carcinogenic Contaminants
Valsartan Recall Lawsuits Filed over Alleged Carcinogenic Contaminants
September 17, 2018
Washington, DC On August 27, 2018, the Food and Drug Administration published updated press information that expands its original July 17 valsartan recall notice. Sixteen companies have now announced voluntary recalls of blood pressure and heart medications READ MORE
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News

READER COMMENTS

Posted by
Debra Loce
on
I have been on Valsartan 320 since 2015. In May on 2018 I was diagnosed with stage II colorectal cancer and colon was removed. Which was tested and did NOT have genetic strain. I have spoken to my cardiologist and he has reviewed my history and will do anything he can to help with case. I am only 52. Have lost wages, job and this has caused much grief and anxiety issues. This has been completely life altering. Please add me to class action lawsuit.

Posted by
eva meadows
on
been on valsartan for yrs. since taking have been diagnosed with fatty liver. unstable pressure 2 strokes. presser as high as 258/116 an 215/126. then falling dangerously low. I have pain in the liver area with a lg. lump in that area also

Posted by
James Lucas
on
I have developed chest congestion and a bad cough over the last 3 to 4 weeks. I have been taking Valsartan for 3 months.
Any advice?

Posted by
Doris Harrah
on
In a call received from a pharmacist for Optum Rx early this month, I was informed that my refill of Valsartan last billed on July 3, 2018 was tainted with a carsenogenic chemical (NDMA).

Recently, I received a disposal system with written direction on how to dispose of the remaining Valsartan.

In a conversation with the Optum pharmacist today, he suggested that I follow up with my treating physician should I have any questions or experience any unusual symptoms.

Posted by
carol beidleman
on
what about people who took the medicine and haven't yet been diagnosed with cancer. is this something that we can get in on

Posted by
Dianne Delay
on
Lung cancer
Never smoked
On Losartan for yrs

Posted by
Billy tyson
on
My husband developed Parkinson.

Posted by
Gloria J Austin
on
I have taken valsartan for many years. The lower part of my right lung was removed in 2017 because of cancer!

Posted by
Maxine Mitchell
on
Is breast cancer caused by Valsartan?

Posted by
Sandra Perera
on
Please call me at 305 336-xxxx

Posted by
Genie Demara
on
Hello,

I have been taking the highest dose of Valsartan for a year now. I do not have any of the symptoms you mention but I am wondering if there is any class action lawsuit against the companies because of the ingestion of toxins.

ADD YOUR COMMENT ON THIS ISSUE

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.
Request Legal Help Now! - Free